NICE Ltd. (NICE)
Quote, stock score, analyst consensus, and SEC filings, plus insider and Congress trades when there are any.
NasdaqGS · Price as of · Nasdaq Real Time Price
- Analysts13
- Implied upside+11.7%
- Target range$100.00 to $170.00
- EPS expected$2.78 -13%
- A year ago$3.18
- Revenue expected$785.7M +7.3%
- Estimate range$2.74 to $2.82
Congress trades in NICE
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-07-20 | Josh Gottheimer NJ | Purchase | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 6-K | October 7, 2026 | 6-K |
| 4 | October 5, 2026 | FORM 4 |
| 4 | October 2, 2026 | View on EDGAR |
| 4 | October 2, 2026 | View on EDGAR |
| 4 | October 2, 2026 | View on EDGAR |
| 4 | September 10, 2026 | View on EDGAR |
| 6-K | September 9, 2026 | 6-K |
| 4 | August 14, 2026 | FORM 4 |
Frequently asked questions
When does NICE report earnings?
NICE Ltd. (NICE) is scheduled to report quarterly results on November 12, 2026, before the open. The 13-analyst consensus is $2.78 per share on revenue of $785.7M for the quarter ended September 30, 2026, against $3.18 and $732.0M a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters.
What do analysts expect for NICE?
13 analysts cover NICE Ltd. (NICE). The consensus rating is Buy. The average price target is $132.77, in a range of $100.00 to $170.00.
Are insiders buying or selling NICE?
We have no qualifying Form 4 insider purchases or sales on record for NICE Ltd. (NICE). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see NICE SEC filings?
Recent filings are listed on this page, newest first. The latest is a 6-K filed October 7, 2026.